HER2 Amplified Solid Tumors
2 clinical trials · Condition
◉ Watch HER2 Amplified Solid Tumors
| Record | Firm | Date |
|---|---|---|
| ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02) (NCT05041972) | Ambrx, Inc. | 2021-11-05 |
| A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers (NCT00911898) | Merrimack Pharmaceuticals | 2009-06-01 |
Track HER2 Amplified Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.